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Abstract
A steady-state bioconcentration and elimination of sulfamethazine (SM2) in the sturgeon (A. schrenkii) was
conducted in flow-through aqueous conditions. Two treated groups of fish were exposed to concentrations of
1.00 and 0.10 mg/L of SM2, respectively. SM2 and its main metabolite, N4-acetyl-SM2, were determined in
both fish muscle and water during the 8-day uptake period and the subsequent 6-day elimination period.
Rapid uptakes of the drug were observed in both treated groups. Muscle tissue residues plateaued after ∼3
days. The bioconcentration factor in muscle (BCFm) in the low-concentration drug solution was 1.19 and that
in the high-concentration-treated level was 0.61. The calculated biodegradation index was 3.72%. The
elimination half-times (t1/2) of the two treatment levels were 19.44 and 23.52 h, respectively. The result
indicates that SM2 will neither bioconcentrate in individual aquatic organisms nor biomagnify in the food
chain, although the BCFm was relatively higher under the low-concentration exposure.
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A steady-state bioconcentration and elimination of sulfamethazine (SM2) in the sturgeon (A. schrenkii)
was conducted in flow-through aqueous conditions. Two treated groups of fish were exposed to
concentrations of 1.00 and 0.10 mg/L of SM2, respectively. SM2 and its main metabolite, N4-acetyl-
SM2, were determined in both fish muscle and water during the 8-day uptake period and the
subsequent 6-day elimination period. Rapid uptakes of the drug were observed in both treated groups.
Muscle tissue residues plateaued after 3 days. The bioconcentration factor in muscle (BCFm) in
the low-concentration drug solution was 1.19 and that in the high-concentration-treated level was
0.61. The calculated biodegradation index was 3.72%. The elimination half-times (t1/2) of the two
treatment levels were 19.44 and 23.52 h, respectively. The result indicates that SM2 will neither
bioconcentrate in individual aquatic organisms nor biomagnify in the food chain, although the BCFm
was relatively higher under the low-concentration exposure.
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INTRODUCTION
Sulfamethazine (SM2) is widely used in food production
animals for therapeutic, prophylactic, and/or growth promotion
purposes (1-3). SM2 produces thyroid follicular tumors in
rodent bioassays. Whether it could lead to similar toxicity from
residue levels has not been tested. Large amounts of SM2 and
its metabolites may also be excreted in feces. The possibility
exists that plentiful application of the drug could result in the
introduction of the drug into nearby bodies of water, leading to
uptake by aquatic organisms. Occurrence and distribution of
SM2 from the pharmaceutical industry have been described in
water down-gradient from a contaminated landfill (4). To assess
the potential impact of SM2 on the environment, the biocon-
centration and elimination were examined in the current study.
Through the evaluation of the natural distribution, bioconcen-
tration, and elimination of SM2 residues following fish exposure
to the treated water, the safety of these residues with respect to
environmental and human exposure can be better assessed.
It is assumed that hydrophobicity, as indicated by the
1-octanol/water partition coefficient (kow) of a compound, is
often the primary screening value for initial prediction of the
tendency of a chemical to bioconcentrate in aquatic species (5,
6). On the basis of laboratory experiments, mathematical
relationships have estimated bioconcentration (BCF). Using the
regression equation derived by Neely (7)
we estimate the BCF of SM2 to be 1.28.
Another physicochemical property that has been used to
predict the bioconcentration is aqueous solubility. An observed
correlation for the trout between BCF and the aqueous solubility
of a variety of compounds, both chlorinated and nonchlorinated
hydrocarbons, was described by the regression equation (6)
S equals the aqueous solubility in ímol/L. Thus, S for SM2 is
1366 ímol/L at neutral pH, which suggests that the potential
bioconcentration is 1.96.
On the basis of the regression equation from the two models
above, SM2 has little potential to bioconcentrate, but the model
based on the equations might not be predictive for compounds
outside the original databases. Furthermore, the model is only
an approximation and useful mainly for neutral organic com-
pounds (5, 7-9). SM2 is an ionizable compound and would
not be expected to have a predictable BCF, because the ambient
pH value would be a contributing factor. Thus, the superior
approach is to actually determine the BCF value from a real
biological system.
Sulfamethazine is known to undergo metabolism to mainly
form N4-acetyl-SM2 in numerous species of domestic animals,
including fish and humans (10-14). Metabolic alteration of the
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parent compound by fish to more polar species or to less polar
species can have an impact upon bioconcentration (5), so N4-
acetyl-SM2, which is less polar than SM2, was used as a
biodegradation marker of the drug in the test organism. The
sturgeon is delicious, reared for food in China nowadays, and
easily available in most areas in China. No literature about the
biotransformation of SM2 in sturgeon has been reported. Thus,
we selected it as the test organism.
Under natural conditions, the drug concentration would go
through a change from high to low, and nontarget organisms
may be exposed to different residual levels. To fully evaluate
the potential for bioconcentration, we designed the experiment
using two drug levels.
MATERIALS AND METHODS
Chemicals. Sulfamethazine was from Sigma (St. Louis, MO). N4-
Acetyl-SM2 was synthesized according to the method of Vree et al.
(12). Sulfamethazine sodium was obtained from the second pharma-
ceutical factory in Beijing, China, and the purity was 99%. Unless
otherwise indicated, chemicals used were all of analytical or HPLC
grade.
Preparation of Standard Solutions. Each standard (10 mg) was
accurately weighed into a 100-mL volumetric flask and diluted with
acetonitrile. Subsequent dilutions (0.01, 0.02, 0.05, 0.10, 0.50, 1.00,
and 2.50 íg/mL) were made with mobile phase.
Test Organism. Juvenile sturgeons of both sexes from the same
year class, with the estimated age of 4-5 months, were obtained from
Miyun County fishery in Beijing. The fish had an initial mean length
of 22.4 ( 3.5 cm and an initial mean weight of 28.2 ( 5.1 g and were
initially held to acclimate for 20 days at 20 ( 1 °C in flow-through
tap water, which had been dechlorinated by exposure to air-bubbling
in advance. Sturgeons were fed standard fish granule food (obtained
from a fishery feed company of Qingdao Oceanic University in China)
daily, and excess food was siphoned from test chambers after feeding.
Test System and Sampling Procedures. The bioaccumulation of
sodium SM2 in sturgeon was studied in glass aquaria containing 528 L
of water. The aquaria (one controlled and two treated) were temperature-
controlled, held at 19-21 °C, and the flow-through resulted in five
volume changes per day in each aquarium.
The treated sturgeons were divided into two groups of high- and
low-dose levels. A primary stock aquarium was prepared with a solution
of SM2 directly dissolved. A peristaltic pump controlled by a rotation-
meter delivered SM2 stock solution to mixing chambers assigned to
the treatment groups. For the two treatment groups, the diluter nominal
aqueous concentrations were 1.00 and 0.10 íg/mL, respectively, and
the resulting water flowed into respective aquaria continuously.
Before study initiation, the test solution from the diluter system was
passed through test aquaria for a 24-h equilibration period, and the
concentrations were confirmed by HPLC analysis.
The uptake phase was initiated by introducing 45 fish into each of
the two treated aquaria and the control aquarium. Immediately after
the 8-day exposure, the flow of SM2 solution to both treatment aquaria
was terminated and the water was removed by siphoning until a depth
of 10 cm of water remained in each aquarium. Aquaria were refilled
and replaced with equal volumes of untreated water. Fishes in both
treatment groups were then exposed to the flow-through clean water
for 6 days. Randomly selected water and fish (three fish and duplicate
10-mL samples of water at each time point) were sampled during
exposure (i.e., days 0.25, 0.5, 1, 2, 3, 4, 5, 6, and 8) and elimination
(i.e., days 8.5, 9, 10, 11, 12, and 13) periods from each aquarium and
then assayed by HPLC.
Extraction and Determination of Residues. For Muscle Residue.
Extraction and cleanup of muscle tissue were performed according to
modified processes reported previously (15-18). Each sample of fish
muscle (without adhering skin) was minced and homogenized in a
homogenizer at high speed for 2 min, and 2 g was accurately weighed
into 50-mL polypropylene centrifuge tubes and mixed with anhydrous
sodium sulfate (5 g). Twenty-five milliliters of acetonitrile was added
to each sample, swirled for 2 min, and shaken for 20 min at room
temperature, and then centrifuged for 10 min at 2500 rpm; the
supernatant was decanted to a 100-mL separatory funnel containing
40 mL of hexane. The separatory funnel was gently shaken for at least
2 min and allowed to stand to separate the layers at room temperature.
The lower aqueous layer was collected to a 50-mL pear-shape flask.
Another 25 mL of acetonitrile was added to the muscle cake and the
above procedure was repeated. The two aqueous phases were combined
and evaporated to near dryness under rotary low-pressure evaporator
at 40 °C, and the residue was dissolved with 5 mL of acetonitrile/
water (95:5, v/v) and applied to an alumina B cartridge (Waters Sep-
Pak Vac 12 cm3, 2 g) that had been pretreated with 12 mL of
acetonitrile/water (95:5, v/v). The column was cleansed with 8 mL of
acetonitrile/water (95:5, v/v) and then eluted with 5 mL of acetonitrile/
water (75:25, v/v). The elution was collected in a 5-mL tube and
evaporated to dryness under a stream of dry nitrogen. The residue was
dissolved in exactly 2 mL of mobile phase, the solution was filtered
through a 0.45-ím membrane, and subsequently 50 íL was injected
into the HPLC system for quantitation.
For Water Residue. Extraction of the chemical residues in water
was achieved by introducing 10 mL of water sample (the pH was
adjusted to 6.5 with diluted acetic acid) into a 100-mL separatory funnel,
followed by a 20-mL aliquot of ethyl acetate (19). The mixture was
shaken vigorously for 5 min and the vapor exhausted; the mixture and
layers were allowed to stand to separate, and the upper, ethyl acetate
layer was collected. Another 20 mL of ethyl acetate was added to the
separatory funnel; it was shaken, allowed to separate, and collected as
before. Then the collected organic portion was evaporated by rotary
evaporation at 40 °C to dryness. Exactly 10 mL of mobile phase was
added to the flask and swirled to mix well. The solution was filtered
through a 0.45-ím membrane, and 50 íL was subsequently injected
into an HPLC system for quantitation.
Liquid Chromatographic Conditions. Characterization of the
isolated residue of the two agents was simultaneously conducted with
a Shimadzu HPLC (consisting of an SCL-10 AVP system controller,
a class VP 5.032 Chemstation, and an SPD-M10 AVP diode array
detector). The separation was performed on Inertsil C18 (5 ím, 250 
4.6 mm i.d.) with acetonitrile/water/acetic acid (24:76:0.05, v/v) as
mobile phase at a flow rate of 1.0 mL/min at room temperature. Typical
chromatograms are presented as Figure 1.
RESULTS AND DISCUSSION
To test the applicability of the method for the simultaneous
determination of two sulfonamides, the standard curves (con-
centration versus chromatographic peak area) were constructed
with standard solutions over a concentration range from 0.01
to 2.50 íg/mL for two drugs. Fifty microliters of each standard
solution was injected in an HPLC system. The linear correlation
coefficients are 0.9995 for SM2 and 0.9998 for N4-acetyl-SM2.
Fortified at 0.02, 0.10, and 2.00 íg/g in muscle, recoveries
were 80.4-89.1% for SM2 and 87.6-106.2% for N4-acetyl-
SM2, with coefficients of variation (CVs) of 2.6-8.4% (SM2)
and 2.1-7.9% (N4-acetyl-SM2). The results are shown in Table
1. The detection limits were 0.01 íg/g for each drug. The
detection limits of the assay were calculated to be 3 times the
peak area of the baseline noise from the drug-free sample.
Fortified at 0.02, 0.10, and 2.00 íg/mL in water, recoveries
were 93.7-96.4% for SM2 and 91.1-102.6% for N4-acetyl-
Table 1. Recoveries and Precisions of the Two Drugs from Fish
Muscles (n ) 5)
drug added (íg/kg) av recovery (%) CV (%)
SM2 20 80.4 8.4
100 85.6 5.3
2000 89.1 2.6
N4-acetyl-SM2 20 106.2 7.9
100 86.0 4.4
2000 87.6 2.1
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SM2, with CVs of 2.6-6.5 and 2.4-5.9%, respectively. The
results are shown in Table 2. The detection limits were 0.01
íg/mL for each drug.
In the whole experiment, the ranges of daily measured
temperature, dissolved oxygen concentration, and pH were 19-
21 °C, 6.4-7.9 íg/mL, and 7.4-7.8, respectively, in all of the
test aquaria, and no statistically significant variation was
calculated between control and treated aquaria. During the whole
test period, neither mortality nor adverse behavior was observed
in treated groups, and no other difference between the controls
and treated was observed either.
Figure 1. Typical chromatograms of (A) 0.10 íg/mL mixed working solution, (B) blank sturgeon muscle, (C) 0.10 íg/g from fortified sturgeon muscle,
(D) blank water, (E) 0.10 íg/mL from fortified water, (F) sample extracted from treated sturgeon muscle on day 1 of the 1.00 íg/mL exposure group,
and (G) sample extracted from treated water on day 1 of the 0.10 íg/mL exposure group. Detection wavelength ) 265 nm. Peaks: 1 ) N4-acetyl-SM2;
2 ) SM2.
Table 2. Recoveries and Precisions of the Two Drugs from Water
(n ) 5)
drug added (íg/L) av recovery (%) CV (%)
SM2 20 93.7 6.5
100 94.5 5.3
2000 96.4 2.6
N4-acetyl-SM2 20 91.1 5.9
100 97.2 4.0
2000 102.6 2.4
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The mean concentrations of SM2 in water, as determined by
HPLC, in the exposure solutions (uptake phase) were 0.101 (
0.004 and 1.008 ( 0.036 íg/mL (mean ( SD), respectively,
for the low and high concentrations, with no value deviating
more than 7.6 and 5.2% from the means, respectively. Con-
centrations of SM2 and its main metabolites, N4-acetyl-SM2, in
water and in the muscle of sturgeon in the two treated groups
over time during an 8-day bioconcentration and 6-day elimina-
tion study are presented in Figures 2 and 3. The acetyl
metabolite was not detected in fish muscle from the low-level
exposure group or in any treated water sample. Concentrations
of SM2 in fish muscle were below the detection limit from day
13. Thus, clearances for fish muscle until elimination day 5 were
both >90%. The data reported in this study were not corrected
for recovery.
The compound was found to fit first-order kinetics with high
correlation coefficients (r > 0.90). The elimination data of the
two groups from days 8-13 were fit to the “exponential curve”
of Y ) Cm e-k2t (21), where Cm is the mean concentration of
SM2 in muscle at day 8 and Y is the concentration of SM2 in
the muscle versus time. The uptake data, days 0-8, were
iteratively fit to the “negative exponential growth curve” of Y
) (k1/k2)Cw(1 - e-k2t) (22), where Cw is the mean solution
concentration of SM2. Fitting was performed using the “procnlin
marquardt” program for SAS 8 statistical software system (23).
The bioconcentration factors in fish muscle (BCFm) at the
high and low drug levels, calculated from the relationship K1/
K2, were 0.61 and 1.19, respectively. These values both agreed
with the day 8 BCFm values from the ratio between the steady-
state residue concentrations in fish muscle and in water, which
were 0.60 and 1.21, respectively. The time required to get 90%
of the steady-state fish muscle concentration from the program
above by regression equation was 3 days. The mean biodeg-
radation index (BI) was calculated from CN4-axcetyl-SM2/(CSM2
+ CN4-acetyl-SM2) in fish muscle from steady-state concentration
data; N4-acetyl-SM2 was counted as the biodegradation product;
the BI was 3.72%. The K1, K2, the mean elimination half-time
values calculated from the elimination curve, and the biocon-
centration factors calculated from Cm/Cw (equivalent to K1/K2)
are also listed in Table 3.
Rapid uptake by the fish was observed, and the residue
plateaued by 3 days. The steady-state bioconcentration factors
for SM2 in fish muscle (BCFm) at the two concentrations were
so low as to be considered of little environmental concern and
are not expected to bioconcentrate into tissues consumed by
humans nor biomagnify in fish consumed by fish predators.
Eliminations in the two exposure levels were also rapid.
Elimination half-lives (t1/2) for SM2 were 19.44 and 23.52 h in
the muscle, respectively, under the high- and low-drug levels.
More than 90% of the drug was eliminated within 3-4 days
after the fish in both exposure levels were placed in uncon-
taminated water.
It is important to note that there are significant differences
between parameters of the two exposure groups, such as K1,
K2, and BCFm. These parameters were determined with two-
sample t test (a ) 0.05). As seen in Table 3, we could conclude
that an ambient concentration exposure to the organism can have
an impact upon pharmacokinetic processes. The comparatively
higher BCF for sturgeon from the lower SM2 concentration
means that low BCFs may be obtained by testing with high
concentrations and vice versa, which is in agreement with reuslts
for other chemicals summarized by Franke (24). Relating the
data to critical body burden concentrations for the respective
ecotoxicological effects will be a better approach for risk
assessment than considering the BCF alone.
In the in ViVo study, the rapid uptake of sulfamethazine and
its low persistence in sturgeon demonstrate that it would neither
bioconcentrate in individual fish nor biomagnify in the food
chain, even if it was introduced into a body of water. Such a
result is similar to that reported with mosquito fish by Coats et
al. (20).
The sturgeon is a good test model organism for it is easy to
rear and easily available. It can be bred and cultivated in fish
farms and in laboratories. With the further development of
aquaculture, more will be available.
ABBREVIATIONS USED
SM2, sulfamethazine; N4-acetyl-SM2, N4-acetylsulfamethaz-
ine; BCFm, bioconcentration factor in muscle; CV, coefficient
of variation.
Table 3. Mean Values of Calculated Uptake Rate Constants (K1) and Elimination Rate Constants (K2), Muscle Bioconcentration Factors (BCFm),
Elimination t1/2, and Biodegradation Index (BI) for SM2 in Sturgeon Muscle
fish muscle K1 (h-1) K2 (h-1) BCFm t1/2 (h) BI (%)
low-dose group (0.10 íg/mL) 20.16 16.80 1.19 (1.00−1.45) 23.52 not detected
high-dose group (1.00 íg/mL) 12.24 20.40 0.61 (0.44−0.70) 19.44 3.72
Figure 2. Measured SM2 residue levels (mean ± SD) in muscle and
water of 0.10 mg/L exposure level to sturgeons during 8-day exposure
and 6-day elimination test.
Figure 3. SM2 and N4-acetyl-SM2 residue levels (mean ± SD) in water
and muscle at 1.00 g/L exposure concentration during 8-day exposure
and 6-day elimination in sturgeons.
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